{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:46:24Z","timestamp":1791927984885,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2023JJB140243"],"award-info":[{"award-number":["2023JJB140243"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cytotechnology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10616-026-01082-9","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:28:18Z","timestamp":1791779298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GP73 regulates autophagy and fibrotic responses in LX-2 cells through the PI3K\/AKT\/mTOR signaling pathway"],"prefix":"10.1007","volume":"78","author":[{"given":"Shuangyan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianying","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuchen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"1","key":"1082_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"MM Ayd\u0131n","year":"2018","unstructured":"Ayd\u0131n MM, Ak\u00e7al\u0131 KC (2018) Liver fibrosis. Turk J Gastroenterol 29(1):14\u201321","journal-title":"Turk J Gastroenterol"},{"key":"1082_CR2","doi-asserted-by":"publisher","first-page":"104720","DOI":"10.1016\/j.phrs.2020.104720","volume":"155","author":"X Cai","year":"2020","unstructured":"Cai X, Wang J, Wang J, Zhou Q, Yang B, He Q, Weng Q (2020) Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacol Res 155:104720","journal-title":"Pharmacol Res"},{"issue":"14","key":"1082_CR3","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.3390\/ijms25147873","volume":"25","author":"H Akk\u0131z","year":"2024","unstructured":"Akk\u0131z H, Gieseler RK, Canbay A (2024) Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells. Int J Mol Sci 25(14):7873","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1082_CR4","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","volume":"79","author":"L Adorini","year":"2023","unstructured":"Adorini L, Trauner M (2023) FXR agonists in NASH treatment. J Hepatol 79(5):1317\u20131331","journal-title":"J Hepatol"},{"issue":"2","key":"1082_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3390\/ijms24021703","volume":"24","author":"R Nevola","year":"2023","unstructured":"Nevola R, Epifani R, Imbriani S, Tortorella G, Aprea C, Galiero R, Rinaldi L, Marfella R, Sasso FC (2023) GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives. Int J Mol Sci 24(2):1703","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1082_CR6","first-page":"5747","volume":"13","author":"M Sun","year":"2021","unstructured":"Sun M, Tan L, Hu M (2021) The role of autophagy in hepatic fibrosis. Am J Transl Res 13(6):5747\u20135757","journal-title":"Am J Transl Res"},{"key":"1082_CR7","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.mam.2021.100973","volume":"82","author":"H Qian","year":"2021","unstructured":"Qian H, Chao X, Williams J, Fulte S, Li T, Yang L, Ding W (2021) X. Autophagy in liver diseases: A review. Mol Aspects Med 82:100973","journal-title":"Mol Aspects Med"},{"key":"1082_CR8","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.biopha.2018.10.005","volume":"108","author":"D Meng","year":"2018","unstructured":"Meng D, Li Z, Wang G, Ling L, Wu Y, Zhang C (2018) Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomed Pharmacother 108:1617\u20131627","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"1082_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jhep.2018.10.015","volume":"70","author":"M Ruart","year":"2019","unstructured":"Ruart M, Chavarria L, Campreci\u00f3s G, Su\u00e1rez-Herrera N, Montironi C, Guix\u00e9-Muntet S, Bosch J, Friedman SL, Garcia-Pag\u00e1n JC (2019) Hern\u00e1ndez-Gea, V. Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury. J Hepatol 70(3):458\u2013469","journal-title":"J Hepatol"},{"issue":"2","key":"1082_CR10","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41419-019-1311-0","volume":"10","author":"D Jia","year":"2019","unstructured":"Jia D, Wang YY, Wang P, Huang Y, Liang DY, Wang D, Cheng C, Zhang C, Guo L, Liang P et al (2019) SVIP alleviates CCl(4)-induced liver fibrosis via activating autophagy and protecting hepatocytes. Cell Death Dis 10(2):71","journal-title":"Cell Death Dis"},{"issue":"6","key":"1082_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jhep.2005.05.028","volume":"43","author":"JA Marrero","year":"2005","unstructured":"Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, Comunale MA, D\u2019Amelio A, Lok AS, Block TM (2005) GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol 43(6):1007\u20131012","journal-title":"J Hepatol"},{"issue":"4","key":"1082_CR12","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1159\/000529815","volume":"41","author":"S Peng","year":"2023","unstructured":"Peng S, Wu Q, Huang X, He X, Li Z, Xu J, Wang L, Zhuang J (2023) Diagnostic Value of Serum Golgi Protein 73 for Liver Fibrosis: A Systematic Review and Meta-Analysis. Dig Dis 41(4):622\u2013631","journal-title":"Dig Dis"},{"issue":"11","key":"1082_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/03000605211055378","volume":"49","author":"Y Li","year":"2021","unstructured":"Li Y, Yang Y, Li Y, Zhang P, Ge G, Jin J, Du T, Ma M, Na L, Ding L et al (2021) Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis. J Int Med Res 49(11):1\u201313","journal-title":"J Int Med Res"},{"issue":"6","key":"1082_CR14","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1053\/jhep.2002.32525","volume":"35","author":"RD Kladney","year":"2002","unstructured":"Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ (2002) Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology 35(6):1431\u20131440","journal-title":"Hepatology"},{"issue":"2","key":"1082_CR15","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s12016-017-8655-y","volume":"54","author":"M Yao","year":"2018","unstructured":"Yao M, Wang L, Leung PSC, Li Y, Liu S, Wang L, Guo X, Zhou G, Yan Y, Guan G et al (2018) The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin Rev Allergy Immunol 54(2):282\u2013294","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"1082_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/FJC.0000000000001487","volume":"83","author":"Y Xing","year":"2024","unstructured":"Xing Y, Gao Z, Bai Y, Wang W, Chen C, Zheng Y, Meng Y (2024) Golgi Protein 73 Promotes LPS-Induced Cardiac Dysfunction via Mediating Myocardial Apoptosis and Autophagy. J Cardiovasc Pharmacol 83(1):116\u2013125","journal-title":"J Cardiovasc Pharmacol"},{"key":"1082_CR17","first-page":"100143","volume":"10","author":"A Gera","year":"2024","unstructured":"Gera A, Yadav L, Patil CR, Posa MK, Chandrakanth B, Kumar S, Oroxylin A (2024) Nature\u2019s arsenal against liver fibrosis, cancer, and inflammatory diseases. Health Sci Rev 10:100143","journal-title":"Health Sci Rev"},{"issue":"5","key":"1082_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.clinre.2019.02.003","volume":"43","author":"Y Lei","year":"2019","unstructured":"Lei Y, Wang QL, Shen L, Tao YY, Liu CH (2019) MicroRNA-101 suppresses liver fibrosis by downregulating PI3K\/Akt\/mTOR signaling pathway. Clin Res Hepatol Gastroenterol 43(5):575\u2013584","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"7","key":"1082_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.pan.2018.08.009","volume":"18","author":"Y-X Song","year":"2018","unstructured":"Song Y-X, Xu Z-C, Li H-L, Yang P-L, Du J-K, Xu J (2018) Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer. Pancreatology 18(7):812\u2013821","journal-title":"Pancreatology"},{"issue":"3","key":"1082_CR20","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jhep.2019.10.028","volume":"72","author":"A Hammoutene","year":"2020","unstructured":"Hammoutene A, Biquard L, Lasselin J, Kheloufi M, Tanguy M, Vion AC, M\u00e9rian J, Colnot N, Loyer X, Tedgui A et al (2020) A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis. J Hepatol 72(3):528\u2013538","journal-title":"J Hepatol"},{"issue":"11","key":"1082_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41580-021-00392-4","volume":"22","author":"YG Zhao","year":"2021","unstructured":"Zhao YG, Codogno P, Zhang H (2021) Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Biol 22(11):733\u2013750","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1082_CR22","doi-asserted-by":"publisher","first-page":"121894","DOI":"10.1016\/j.lfs.2023.121894","volume":"329","author":"S Siapoush","year":"2023","unstructured":"Siapoush S, Rezaei R, Alavifard H, Hatami B, Zali MR, Vosough M, Lorzadeh S, \u0141os MJ, Baghaei K, Ghavami S (2023) Therapeutic implications of targeting autophagy and TGF-\u03b2 crosstalk for the treatment of liver fibrosis. Life Sci 329:121894","journal-title":"Life Sci"},{"issue":"9","key":"1082_CR23","first-page":"874","volume":"5","author":"MC Ba","year":"2012","unstructured":"Ba MC, Long H, Tang YQ, Cui SZ (2012) GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review. Int J Clin Exp Pathol 5(9):874\u2013881","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"1082_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41389-021-00358-3","volume":"10","author":"Y Liu","year":"2021","unstructured":"Liu Y, Wang J, Yang R, Cheng Y, Zhou Y, Li H, Jiang W, Zhang X (2021) GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells. Oncogenesis 10(10):69","journal-title":"Oncogenesis"},{"issue":"6","key":"1082_CR25","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.4103\/0973-1482.199784","volume":"14","author":"C Jiao","year":"2018","unstructured":"Jiao C, Cui L, Piao J, Qi Y, Yu Z (2018) Clinical significance and expression of serum Golgi protein 73 in primary hepatocellular carcinoma. J Cancer Res Ther 14(6):1239\u20131244","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"1082_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","volume":"142","author":"V Hern\u00e1ndez-Gea","year":"2012","unstructured":"Hern\u00e1ndez-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, Czaja MJ, Friedman SL (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142(4):938\u2013946","journal-title":"Gastroenterology"},{"issue":"8","key":"1082_CR27","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1080\/15548627.2015.1058473","volume":"11","author":"J Lodder","year":"2015","unstructured":"Lodder J, Dena\u00ebs T, Chobert MN, Wan J, El-Benna J, Pawlotsky JM, Lotersztajn S, Teixeira-Clerc F (2015) Macrophage autophagy protects against liver fibrosis in mice. Autophagy 11(8):1280\u20131292","journal-title":"Autophagy"},{"issue":"5","key":"1082_CR28","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1007\/s13277-014-2974-x","volume":"36","author":"YY Zhou","year":"2015","unstructured":"Zhou YY, Jiang JC, You J, Zhou LF (2015) Effect of Golgi phosphoprotein 2 (GOLPH2\/GP73) on autophagy in human hepatocellular carcinoma HepG2 cells. Tumour Biol 36(5):3399\u20133406","journal-title":"Tumour Biol"},{"key":"1082_CR29","first-page":"1","volume":"13","author":"X Lin","year":"2022","unstructured":"Lin X, Wei Y, Li Y, Xiong Y, Fang B, Li C, Huang Q, Huang R, Wei J (2022) Tormentic Acid Ameliorates Hepatic Fibrosis in vivo by Inhibiting Glycerophospholipids Metabolism and PI3K\/Akt\/mTOR and NF-\u03baB Pathways: Based on Transcriptomics and Metabolomics. Front Pharmacol 13:1\u201313","journal-title":"Front Pharmacol"},{"key":"1082_CR30","doi-asserted-by":"publisher","first-page":"176552","DOI":"10.1016\/j.ejphar.2024.176552","volume":"971","author":"WY Cheng","year":"2024","unstructured":"Cheng WY, Zeng XX, Cheng P, Zhang JX (2024) Loureirin B ameliorates cholestatic liver fibrosis via AKT\/mTOR\/ATG7-mediated autophagy of hepatic stellate cells. Eur J Pharmacol 971:176552","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1082_CR31","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/pros.23461","volume":"78","author":"G Yan","year":"2018","unstructured":"Yan G, Ru Y, Wu K, Yan F, Wang Q, Wang J, Pan T, Zhang M, Han H, Li X et al (2018) GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling. Prostate 78(3):166\u2013177","journal-title":"Prostate"}],"container-title":["Cytotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-026-01082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10616-026-01082-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10616-026-01082-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:11Z","timestamp":1791925391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10616-026-01082-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1082"],"URL":"https:\/\/doi.org\/10.1007\/s10616-026-01082-9","relation":{},"ISSN":["0920-9069","1573-0778"],"issn-type":[{"value":"0920-9069","type":"print"},{"value":"1573-0778","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not Applicable. This article does not contain any studies with human participants or animals performed by any of the authors.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors did not use any AI-assisted technology.","order":4,"name":"Ethics","label":"Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"211"}}